SAN FRANCISCO: A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis — a new wave of scrutiny of the high cost of its insulin. “Fake Eli Lilly might be offering something closer to the truth than real Eli Lilly,” Peter Maybarduk, from the nonprofit Public Citizen, told AFP. The backlash against Eli Lilly showcased the real-life potential of online disinformation to trigger chaos and financial loss. By Friday, Eli Lilly executives ordered a halt to all ad campaigns on Twitter, a move that could potentially cost the platform millions of dollars. Eli Lilly and Twitter did not respond to AFP‘s request for comment.

Source: Pakistan Today November 15, 2022 18:43 UTC